Summary of First Rabies Challenge Results

Attention: open in a new window. PDFPrintE-mail

Posted June 24, 2015

The first trial in the final challenge phase of The Rabies Challenge Fund research has been completed.  The data yielded mixed results, which are not applicable to our goals of determining the long-term duration of immunity of the rabies vaccine in dogs and establishing a canine rabies titer.

Our challenge was conducted in a USDA-approved facility by a group of researchers using the USDA Title 9 standard for rabies vaccine licensing, upon which The National Association of State Public Health Veterinarian’s Rabies Compendium and state laws are based.  That standard requires that 80% of the control dogs test positive for rabies disease.  Only one (10%) of the 5 control dogs tested positive for disease, while another tested positive for infection.  None of the ten vaccinates tested positive for rabies disease or infection. 

These results show that the challenge virus used by the investigators in this first trial was not virulent enough to cause disease in 80% of the control dogs.

It is our intention to conduct another challenge using a new highly virulent challenge virus from the USDA, which has been successfully used in recent canine rabies trials.



Year 7 Donations

$180,000
donation thermometer
donation thermometer
$129,657
donation thermometer
72%
Updated:
3/10/16

Quick Links

Donate today

Help get us to the fundraising finish line.

Join our Mailing List

Receive timely updates and important action alerts.

Look Who's Endorsing the Rabies Challenge Fund

Rin Tin Tin, Benji and and award-winning author Jan Rasmusen all endorse the RCF.

Join Our Facebook Community

Join our community and connect with other supporters of the RCF.

Thank You!

The Rabies Challenge Fund is a grassroots, team effort. Every contribution, regardless of size, moves us closer to our goal. We thank all the individuals, businesses, and breed clubs, canine clubs and associations for their generous support.

The Rabies Challenge Fund is a 501(c)(3) charitable organization studying the duration of immunity conveyed by rabies vaccines.